The objective of this project is to use pharmacogenomic testing and interpretation to guide therapy, optimize medication use and identify and resolve drug therapy problems in patients with mental health conditions, including depression and anxiety. Pharmacy will partner with provider teams to identify candidates for testing based on clinical picture including polypharmacy, a history of adverse drug reactions, or multiple failed therapies for psychiatric conditions.